JP2023539694A5 - - Google Patents
Info
- Publication number
- JP2023539694A5 JP2023539694A5 JP2023537723A JP2023537723A JP2023539694A5 JP 2023539694 A5 JP2023539694 A5 JP 2023539694A5 JP 2023537723 A JP2023537723 A JP 2023537723A JP 2023537723 A JP2023537723 A JP 2023537723A JP 2023539694 A5 JP2023539694 A5 JP 2023539694A5
- Authority
- JP
- Japan
- Prior art keywords
- acrylamide
- methyl
- alkyl
- compound according
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013728.7 | 2020-09-01 | ||
| GBGB2013728.7A GB202013728D0 (en) | 2020-09-01 | 2020-09-01 | Novel compounds |
| PCT/GB2021/052261 WO2022049376A1 (en) | 2020-09-01 | 2021-09-01 | Novel compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539694A JP2023539694A (ja) | 2023-09-15 |
| JP2023539694A5 true JP2023539694A5 (cg-RX-API-DMAC10.html) | 2024-09-09 |
| JP7784430B2 JP7784430B2 (ja) | 2025-12-11 |
Family
ID=72749708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537723A Active JP7784430B2 (ja) | 2020-09-01 | 2021-09-01 | 新規化合物 |
Country Status (12)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202013731D0 (en) | 2020-09-01 | 2020-10-14 | Nrg Therapeutics Ltd | Novel cmpounds |
| WO2023209651A1 (en) * | 2022-04-29 | 2023-11-02 | Dong-A St Co., Ltd. | Bicycle compounds as tead inhibitor |
| GB202300833D0 (en) | 2023-01-19 | 2023-03-08 | Nrg Therapeutics Ltd | Novel compounds |
| CN119306612B (zh) * | 2023-07-14 | 2026-03-20 | 中国科学院大连化学物理研究所 | 一种反式氨基茚满的制备方法 |
| CN121866248A (zh) | 2023-09-05 | 2026-04-14 | Nrg治疗有限公司 | 作为mptp抑制剂起作用的吡啶衍生物 |
| GB202410534D0 (en) | 2024-07-18 | 2024-09-04 | Nrg Therapeutics Ltd | Novel method and uses |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2852659B2 (ja) * | 1988-03-03 | 1999-02-03 | 富山化学工業株式会社 | ピペラジン誘導体およびその塩 |
| JPWO2003020313A1 (ja) | 2001-09-04 | 2004-12-16 | 小野薬品工業株式会社 | スフィンゴシン−1−リン酸受容体調節剤からなる呼吸器疾患治療剤 |
| AU2002354476A1 (en) | 2001-12-14 | 2003-06-30 | Japan Tobacco Inc. | Pyrazolopyridine derivatives and medicinal use thereof |
| JP2006512306A (ja) * | 2002-08-29 | 2006-04-13 | テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途 |
| JP2006160916A (ja) * | 2004-12-08 | 2006-06-22 | Fuji Photo Film Co Ltd | インクジェット用インク組成物及びインクジェット記録方法 |
| JP5495206B2 (ja) | 2006-10-24 | 2014-05-21 | コンジエニア・ソシエタ・ア・レスポンサビリタ・リミタータ | 変性性組織障害をmptの阻害により防止するための薬剤としてのフェニル置換マレイミド |
| EP2179984A1 (en) | 2008-10-27 | 2010-04-28 | Congenia S.r.l. | Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| WO2011087051A1 (ja) | 2010-01-14 | 2011-07-21 | 国立大学法人金沢大学 | S1p2受容体アンタゴニストを含む粥状動脈硬化治療薬 |
| JP5990106B2 (ja) | 2011-01-28 | 2016-09-07 | 佐藤製薬株式会社 | 縮環化合物 |
| JP2017538676A (ja) | 2014-11-05 | 2017-12-28 | ザ ユニバーシティ オブ カンザス | ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤 |
| WO2016090371A2 (en) | 2014-12-05 | 2016-06-09 | An2H Discovery Limited | Parkin ligase activation methods and compositions |
| CA2884607A1 (en) | 2015-03-11 | 2016-09-11 | Stealth Peptides International, Inc. | Therapeutic compositions including acrylamido compounds or phenyl-substiituted maleimide compounds and uses thereof to treat and prevent mitochondrial diseases and conditions |
| WO2019002624A1 (de) | 2017-06-30 | 2019-01-03 | Kleuser, Burkhard | Mittel zur therapie entzündlicher darmerkrankungen |
| GB202013731D0 (en) | 2020-09-01 | 2020-10-14 | Nrg Therapeutics Ltd | Novel cmpounds |
-
2020
- 2020-09-01 GB GBGB2013728.7A patent/GB202013728D0/en not_active Ceased
-
2021
- 2021-09-01 MX MX2023002525A patent/MX2023002525A/es unknown
- 2021-09-01 CN CN202180053567.3A patent/CN116096705A/zh active Pending
- 2021-09-01 US US18/023,558 patent/US12630516B2/en active Active
- 2021-09-01 IL IL300900A patent/IL300900A/en unknown
- 2021-09-01 ES ES21769789T patent/ES3055772T3/es active Active
- 2021-09-01 EP EP21769789.5A patent/EP4208442B1/en active Active
- 2021-09-01 AU AU2021337195A patent/AU2021337195A1/en not_active Abandoned
- 2021-09-01 KR KR1020237007646A patent/KR20230069915A/ko not_active Withdrawn
- 2021-09-01 JP JP2023537723A patent/JP7784430B2/ja active Active
- 2021-09-01 CA CA3190645A patent/CA3190645A1/en active Pending
- 2021-09-01 WO PCT/GB2021/052261 patent/WO2022049376A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100704215B1 (ko) | 8-아자프로스타글란딘 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제 | |
| AU2015361018B2 (en) | 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones | |
| JP2024086819A (ja) | 化合物、組成物、及び、方法 | |
| JP2023539695A5 (cg-RX-API-DMAC10.html) | ||
| JP2025508898A5 (cg-RX-API-DMAC10.html) | ||
| JP2024166311A (ja) | 化合物、組成物、及び、方法 | |
| AR059895A1 (es) | Derivados biciclicos de acidos carboxilicos que resultan de utilidad para tratar trastornos metabolicos | |
| NZ601967A (en) | Pde10 inhibitors and related compositions and methods | |
| JP2018531981A5 (cg-RX-API-DMAC10.html) | ||
| CN1610557A (zh) | 6-氟双环[3.1.0]己烷衍生物 | |
| CN102471296A (zh) | Bace抑制剂 | |
| PE20091444A1 (es) | Derivados de isoxazolo-pirazina | |
| JP2022540434A5 (cg-RX-API-DMAC10.html) | ||
| JP2023503331A5 (cg-RX-API-DMAC10.html) | ||
| HUE034820T2 (en) | Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B | |
| BRPI1014050A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| PL209339B1 (pl) | Pochodne dioksano-2- alkilokarbaminianów, sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie | |
| JP2023503601A5 (cg-RX-API-DMAC10.html) | ||
| JP6454335B2 (ja) | カテプシンシステインプロテアーゼ阻害剤 | |
| WO2023107648A3 (en) | Synthesis of ester, carbonate, and carbamate-derived novel biodegradable ionizable lipids from methyl ricinoleate or methyl 12-hydroxystearate and its applications | |
| JP2023535926A5 (cg-RX-API-DMAC10.html) | ||
| JP2023123607A (ja) | ベンゼン誘導体 | |
| BR112021007784A2 (pt) | processo para preparar compostos de isoxazolina opticamente enriquecidos | |
| WO2018102399A1 (en) | Methods of dose administration for treating or preventing cognitive impairment using indane acetic acid derivatives | |
| HRP20170485T1 (hr) | Derivati 1-[1-(benzoil)pirolidin-2-karbonil]pirolidin-2-karbonitrila |